SEC Company Response from OptimizeRx Corp (OPRX) (CIK 0001448431) (OPRX) — Jun 12, 2015
OptimizeRx Corp (OPRX) (CIK 0001448431)
Date: June 12, 2015 · CIK: 0001448431 · Accession: 0001213900-15-004450
AI Filing Summary & Sentiment
File numbers found in text: 333-203820
Letter
Division of Corporation Finance Washington, D.C. 20549-7010 Re: OptimizeRx Corp Registration Statement on Form S-1 File No. 333-203820
Dear Mr. Kauten:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 to 4:00 PM Eastern Standard Time on June 16, 2015, or as soon thereafter as is practicable.
The Company acknowledges the following:
● Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your assistance. Please call with any questions.
OptimizeRx Corp
By: /s/ Doug Baker
Doug Baker
Chief Financial Officer
400 Water Street Suite 200
Rochester, MI, 48307- Phone: 248 651-6568
Show Raw Text
CORRESP
1
filename1.htm
OptimizeRx
Corp
June 12, 2015
THE UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Attn: Jeff Kauten
Division of Corporation Finance
Mail Stop 7010
100 F. Street NE
Washington, D.C. 20549-7010
Re:
OptimizeRx Corp
Registration Statement on Form S-1
File No. 333-203820
Dear Mr. Kauten:
Pursuant to Rule 461 under the Securities Act
of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration
Statement on Form S-1 to 4:00 PM Eastern Standard Time on June 16, 2015, or as soon thereafter as is practicable.
The Company acknowledges the following:
● Should the Commission or the staff, acting pursuant to delegated authority, declare the filing
effective, it does not foreclose the Commission from taking any action with respect to the filing;
● The action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure
in the filing; and
● The Company may not assert staff comments and the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your assistance. Please call
with any questions.
OptimizeRx Corp
By:
/s/ Doug Baker
Doug Baker
Chief Financial Officer
400 Water Street Suite 200
Rochester, MI, 48307- Phone: 248 651-6568